Navigation Links
Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
Date:5/21/2008

ated with long-term survival in many patients, including four who survived for 11 to over 18 months. Mechanism-of-action of JX-594 was validated in patients by demonstration of tumor-specific replication and tissue destruction with JX- 594, in addition to high-level active expression of the GM-CSF protein in the blood of patients. These results led to the initiation of a Phase II liver cancer trial that is now open in the U.S., and will shortly begin enrolling patients at sites in South Korea and Canada, as well.

About JX-594

JX-594 is a cancer biotherapeutic, currently in Phase II trials, from a proprietary class of targeted and armed oncolytic poxviruses. Tumor destruction and safety was shown in patients with diverse cancer types in three Phase I trials; treated patients were end-stage and had no effective therapies available. JX-594 multiplies selectively within cancer cells, leading to their destruction. These newly created copies of JX-594 are then released and are able to infect and eradicate other tumor cells both locally and in distant sites in the body. This cycle of JX-594 replication, cancer cell destruction, release and spread is then repeated. Normal cells are not affected by JX-594 resulting in safety and tolerability. The poxvirus strain backbone of JX-594 has been used safely in millions of people as part of a worldwide vaccination program against smallpox. This strain naturally targets cancer cells due to common genetic defects in cancer cells. JX-594 was engineered to enhance this natural safety and cancer-selectivity by deleting its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the GM-CSF protein. GM-CSF complements the cancer cell lysis work of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and an anti-tumoral immune attack.
'/>"/>

SOURCE Jennerex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
7. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
10. Promising Cystic Fibrosis Compound on Track for Development
11. Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015 According to a new market ... Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type ... published by MarketsandMarkets, the Medical Lifting Sling Market is poised to ... 2015, at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  Now that ... the Da Vinci S™ surgical robot, hospitals with robotic ... plans. They also need to see where they stand ... on the right patients? Have they adopted best practices ... surgery program in the future? ECRI Institute, ...
(Date:8/27/2015)... 2015   Proxsys Rx, the nation,s ... expanding its population health management services with ... care program for hospitals and health systems. ... with technology systems and pharmacy support services ... been mandated by Center for Medicare and ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... AirPal ®, a leading innovator and supplier ... the expansion of its line of air-activated transfer pads ... announcement marks the launch of an entire new series ... President AirPal, Inc.  "Among other functions, these exciting new ...
... recently merged with World Wide Relics (OTC Bulletin Board: ... its name to China PharmaHub Corp, is proud to ... Yongkon Pharmacy Co. Ltd., ("Yongkon"), a pharmaceutical company based ... 2600 hospitals in China.  PharmaHub was authorized by Yongkon ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 3
(Date:8/28/2015)... MO (PRWEB) , ... August 28, 2015 , ... ... testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement Therapy Products ... a cap on the number of custodial files the PSC may receive for ...
(Date:8/28/2015)... ... ... Super-Sod launched their new website this summer. The new user-friendly ... the responsive web design. Website users will now have an improved browsing experience on ... sod, sign-up for the monthly turf-tips email, and find a local Super-Sod store all ...
(Date:8/28/2015)... ... 2015 , ... The Wilson and Juanita Mann Health Center ... a patient’s quality of life through early diagnosis and treatment. The focus is ... HIV/AIDS, STDs, and others. A Women’s, Infants & Children (WIC) clinic also provides ...
(Date:8/27/2015)... ... August 28, 2015 , ... Grace Bay Beach has been recognized ... to an already impressive list of accolades for the Turks and Caicos so far ... beach in the world by TripAdvisor, the world's leading authority on travel. , ...
(Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of 10 ... and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to assist ... a $7,500 scholarship to assist in his goal of becoming a foreign diplomat with ...
Breaking Medicine News(10 mins):Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Grace Bay Beach Acknowledged as a Top Caribbean Beach for Weddings 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3
... College Park, MD (November 30, 2007) Concerns over possible ... in the New England Journal of Medicine should not scare ... scans play a critical role in saving the lives of ... the American Association of Physicists in Medicine (AAPM). , In ...
... of relationships between parents and their adult children improve ... researcher has found. , Karen Fingerman, an associate professor ... Consumer and Family Sciences, examined relationships adults 70 and ... offspring. The parents in the study also suffered either ...
... a third, study found , , FRIDAY, Nov. 30 (HealthDay ... significantly slows the decline in lung function seen in ... team at Case Western Reserve University School of Medicine, ... took high doses of ibuprofen twice a day had ...
... and Ceramic Oxides, BATON ROUGE, La., Nov. ... world leader in the development and marketing,of aluminum ... and other industrial applications, will increase the prices ... percent, effective globally on all,shipment made on or ...
... Ltd., (Amex: CPD ) announced today that ... tentative approval for the Company,s,Abbreviated New Drug Application ... mg, and 20 mg., Escitalopram is indicated ... approval is for the generic bioequivalent product,to Lexapro(R), ...
... Enhance Cardiovascular Fitness, Improve Health and Balance, and Promote ... ... today unveiled a revolutionary new fitness system that combines the,benefits of dance ... the first time to the adult market., This innovative and groundbreaking ...
Cached Medicine News:Health News:Hazards of CT scans overstated 2Health News:Aging improves parent, child relationships, research shows 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 3Health News:Albemarle Raises Prices of Specialty Aluminas 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) 2Health News:The Dancetown Fitness System: a Radical New Approach to Physical Exercise for Adults Combines State-of-the-Art Computer Technology and Dance 2
... a highly featured laser doppler system ... perfusion from multiple tissue sites. This ... Digital Signal Processing (DSP) and laser ... yet simple to use, multi-channel monitor, ...
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... product from Viasys Neurocare is a full-featured physiologic ... portable size. It contains many of the features ... offered at an economical price. , ,The smaller ... a crowded lab environment, the physician's office, a ...
Medicine Products: